Assessment of biofilm formation by Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans

References

• Abi-Chacara EA, Souza LOP, Cruz LP, Braga-Silva LA, Gonçalves DS, Sodré CL, Ribeiro MD, Seabra SH, Figueiredo-Carvalho MHG, Barbedo LS, et al. 2013. Phenotypical properties associated with virulence from clinical isolates belonging to the Candida parapsilosis complex. FEMS Yeast Res. 13:831–848. doi:10.1111/1567-1364.12092.
   PubMed Web of Science ®Google Scholar
• Beauvais A, Fontaine T, Aimanianda V, Latgé JP. 2014. Aspergillus cell wall and biofilm. Mycopathologia. 178:371–377. doi:10.1007/s11046-014-9766-0.
   PubMed Web of Science ®Google Scholar
• Beauvais A, Schmidt C, Guadagnini S, Roux P, Perret E, Henry E, Paris S, Mallet A, Prévost MC, Latgé JP. 2007. An extracellular matrix glues together the aerial-grown hyphae of Aspergillus fumigatus. Cell Microbiol. 9:1588–1600. doi:10.1111/j.1462-5822.2007.00895.x.
   PubMed Web of Science ®Google Scholar
• Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 183:5385–5394. doi:10.1128/JB.183.18.5385-5394.2001.
   PubMed Web of Science ®Google Scholar
• Choi NYC, Kang SY, Kim KJ. 2015. Artemisia princeps inhibits biofilm formation and virulence-factor expression of antibiotic-resistant bacteria. Biomed Res Int. 2015: 239519. doi:10.1155/2015/239519.
   Web of Science ®Google Scholar
• CLSI – Clinical Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. 2nd ed. Wayne (PA): CLSI. CLSI Document M38-A2; p. 52.
   Google Scholar
• Cortez KJ, RoilIdes E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T, Buchanan W, Milanovich J, Sutton D, Fothergill A, et al. 2008. Infections caused by Scedosporium spp. Clin Microbiol Rev. 21:157–197. doi:10.1128/CMR.00039-07.
   PubMed Web of Science ®Google Scholar
• Cos P, Toté K, Horemans T, Maes L. 2010. Biofilms: an extra hurdle for effective antimicrobial therapy. Curr Pharm Des. 16:2279–2295. doi:10.2174/138161210791792868.
   PubMed Web of Science ®Google Scholar
• Costa-Orlandi CB, Sardi JCO, Santos CT, Fusco-Almeida AM, Mendes-Giannini MJS. 2014. In vitro characterization of Trichophyton rubrum and T. mentagrophytes biofilms. Biofouling. 30:719–727. doi:10.1080/08927014.2014.919282.
   PubMed Web of Science ®Google Scholar
• Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D’Antonio D, Piccolomini R. 2006. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob Agents Chemother. 50:3269–3276. doi:10.1128/AAC.00556-06.
   PubMed Web of Science ®Google Scholar
• Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 15:167–193. doi:10.1128/CMR.15.2.167-193.2002.
   PubMed Web of Science ®Google Scholar
• Fanning S, Mitchell AP. 2012. Fungal biofilms. PLoS Pathog. 8:e1002585. doi:10.1371/journal.ppat.1002585.
   PubMed Web of Science ®Google Scholar
• Filler SG, Sheppard DC. 2006. Fungal invasion of normally nonphagocytic host cells. PLoS Pathog. 2:e129. doi:10.1371/journal.ppat.0020129.
   PubMed Web of Science ®Google Scholar
• Flemming HC, Wingender J. 2010. The biofilm matrix. Nat Rev Microbiol. 8:623–633. doi:10.1038/nrmicro2415.
   PubMed Web of Science ®Google Scholar
• Harding MW, Marques LL, Howard RJ, Olson ME. 2009. Can filamentous fungi form biofilms? Trends Microbiol. 17:475–480. doi:10.1016/j.tim.2009.08.007.
   PubMed Web of Science ®Google Scholar
• Hohl TM, van Epps HL, Rivera A, Morgan LA, Chen PL, Feldmesser M, Pamer EG. 2005. Aspergillus fumigatus triggers inflammatory responses by stage-specific β-glucan display. PLoS Pathog. 1:e30. doi:10.1371/journal.ppat.0010030.
   PubMed Web of Science ®Google Scholar
• Hope WW, Walsh TJ, Denning DW. 2005. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol. 43:S207–S238. doi:10.1080/13693780400025179.
   PubMed Web of Science ®Google Scholar
• Kaltseis J, Rainer J, Hoog De. 2009. Ecology of Pseudallescheria and Scedosporium species in human-dominated and natural environments ad their distribution in clinical samples. Med Mycol. 47:398–405. doi:10.1080/13693780802585317.
   PubMed Web of Science ®Google Scholar
• Kaur S, Singh S. 2014. Biofilm formation by Aspergillus fumigatus. Med Mycol. 52:2–9. doi:10.3109/13693786.2013.819592.
   PubMed Web of Science ®Google Scholar
• Kojic EM, Darouiche RO. 2004. Candida infections of medical devices. Clin Microbiol Rev. 17:255–267. doi:10.1128/CMR.17.2.255-267.2004.
   PubMed Web of Science ®Google Scholar
• Kolter R, Greenberg EP. 2006. Microbial sciences: the superficial life of microbes. Nature. 441:300–302. doi:10.1038/441300a.
   PubMed Web of Science ®Google Scholar
• Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. 2002. Comparasion of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun. 70:878–888. doi:10.1128/IAI.70.2.878-888.2002.
   PubMed Web of Science ®Google Scholar
• Lackner M, Guarro J. 2013. Pathogenesis of Scedosporium. Curr Fungal Infect Rep. 7:326–333. doi:10.1007/s12281-013-0157-7.
   Google Scholar
• Lackner M, Hoog GS, Verweij PE, Najafzadeh MJ, Curfs-Breuker I, Klaassen CH, Meis JF. 2012. Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species. Antimicrob Agents Chemother. 56:2635–2642. doi:10.1128/AAC.05910-11.
   PubMed Web of Science ®Google Scholar
• Lopez D, Vlamakis H, Kolter R. 2010. Biofilms. Cold Spring Harb Perspect. Biol. 2:a000398. doi:10.1101/cshperspect.a000398.
   Google Scholar
• Loussert C, Schmitt C, Prevost MC, Balloy V, Fadel E, Philippe B, Kauffmann-Lacroix C, Latgé JP, Beauvais A. 2010. In vivo biofilm composition of Aspergillus fumigatus. Cell Microbiol. 12:405–410. doi:10.1111/j.1462-5822.2009.01409.x.
   PubMed Web of Science ®Google Scholar
• Mowat E, Butcher J, Lang S, Williams C, Ramage G. 2007. Development of a simple model for studying the effects of antifungal agents on multicellular communities of Aspergillus fumigatus. J Med Microbiol. 56:1205–1212. doi:10.1099/jmm.0.47247-0.
   PubMed Web of Science ®Google Scholar
• Mowat E, Lang S, Williams C, McCulloch E, Jones B, Ramage G. 2008. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicelular filamentous biofilms. J Antimicrob Chemother. 62:1281–1284. doi:10.1093/jac/dkn402.
   PubMed Web of Science ®Google Scholar
• Mowat E, Williams C, Jones B, Mcchlery S, Ramage G. 2009. The characteristics of Aspergillus fumigatus mycetoma development: is this a biofilm? Med Mycol. 47:S120–S126. doi:10.1080/13693780802238834.
   PubMed Web of Science ®Google Scholar
• Müller FM, Seidler M, Beauvais A. 2011. Aspergillus fumigatus biofilms in the clinical setting. Med Mycol. 49:S96–S100. doi:10.3109/13693786.2010.502190.
   PubMed Web of Science ®Google Scholar
• Osherov N, May S. 2001. The molecular mechanisms of conidial germination. FEMS Microbiol Lett. 199:153–160. doi:10.1016/S0378-1097(01)00178-1.
   PubMed Web of Science ®Google Scholar
• Park HR, Voigt K. 2014. Interaction of Zygomycetes with innate immune cells reconsidered with respect to ecology, morphology, evolution and infection biology: a mini-review. Mycoses. 57:31–39. doi:10.1111/myc.12235.
   PubMed Web of Science ®Google Scholar
• Peeters E, Nelis HJ, Coenye T. 2008. Comparasion of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods. 72:157–165. doi:10.1016/j.mimet.2007.11.010.
   PubMed Web of Science ®Google Scholar
• Priegnitz BE, Wargenau A, Brandt U, Rohde M, Dietrich S, Kwade A, Krull R, Fleissner A. 2012. The role of initial spore adhesion in pellet and biofilm formation in Aspergillus niger. Fungal Genet Biol. 49:30–38. doi:10.1016/j.fgb.2011.12.002.
   PubMed Web of Science ®Google Scholar
• Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J. 2009. Our current understanding of fungal biofilms. Crit Rev Microbiol. 35:340–355. doi:10.3109/10408410903241436.
   PubMed Web of Science ®Google Scholar
• Ramage G, Rajendran R, Gutierrez-Correa M, Jones B, Williams C. 2011. Aspergillus biofilms: clinical and industrial significance. FEMS Microbiol Lett. 324:89–97. doi:10.1111/j.1574-6968.2011.02381.x.
   PubMed Web of Science ®Google Scholar
• Ramage G, Robertson SN, Williams C. 2014. Strength in numbers: antifungal strategies against fungal biofilms. Int J Antimicrob Agents. 43:114–120. doi:10.1016/j.ijantimicag.2013.10.023.
   PubMed Web of Science ®Google Scholar
• Ramage G, Saville SP, Thomas DP, López-Ribot JL. 2005. Candida biofilms: an update. Eukaryot Cell. 4:633–638. doi:10.1128/EC.4.4.633-638.2005.
   PubMed Web of Science ®Google Scholar
• Reinhart H, Muller G, Sobel JD. 1985. Specificity and mechanism of in vitro adherence of Candida albicans. Ann Clin Lab Sci. 15:406–413.
   PubMed Web of Science ®Google Scholar
• Sangheta S, Zureini Z, Suryani S, Sasidharan S. 2009. In situ TEM and SEM studies on the antimicobial activity and provention of Candida albicans biofilm by Cassiaspctablis extracts. Micron Biotechnol. 40:439–443. doi:10.1016/j.micron.2009.01.003.
   Web of Science ®Google Scholar
• Santos ALS, Mello TP, Ramos LS, Branquinha MH. 2015. Biofilm: a robust and efficient barrier to antifungal chemotherapy. J Antimicrobial Agents. 1:e101. doi:10.4172/Antimicro.1000e101.
   Google Scholar
• Sardi JC, Pitangui NS, Rodríguez-Arellanes G, Taylor ML, Fusco-Almeida AM, Mendes-Giannini MJ. 2014. Highlights in pathogenic fungal biofilms. Rev Iberoam Micol. 31:22–29. doi:10.1016/j.riam.2013.09.014.
   PubMed Web of Science ®Google Scholar
• Seidler MJ, Salvenmoser S, Müller FM. 2008. Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells. Antimicrob Agents Chemother. 52:4130–4136. doi:10.1128/AAC.00234-08.
   PubMed Web of Science ®Google Scholar
• Shibuya K, Ando T, Hasegawa C, Wakayama M, Hamatani S, Hatori T, Nagayama T, Nonaka H. 2004. Pathophysiology of pulmonary aspergillosis. J Infect Chemother. 10:138–145. doi:10.1007/s10156-004-0315-5.
   PubMedGoogle Scholar
• Silva BA, Pinto MR, Soares RMA, Barreto-Bergter E, Santos ALS. 2006. Pseudallescheria boydii releases metallopeptidases capable of cleaving several proteinaceous compounds. Res Microbiol. 157:425–432. doi:10.1016/j.resmic.2005.11.010.
   PubMed Web of Science ®Google Scholar
• Singh R, Shivaprakash MR, Chakrabarti A. 2011. Biofilm formation by zygomycetes: quantification, structure and matrix composition. Microbiology. 157:2611–2618. doi:10.1099/mic.0.048504-0.
   PubMed Web of Science ®Google Scholar
• Singhal D, Baker L, Wormald PJ, Tan L. 2011. Aspergillus fumigatus biofilm on primary human sinonasal epithelial culture. Am J Rhinol Allergy. 25:219–225. doi:10.2500/ajra.2011.25.3622.
   PubMed Web of Science ®Google Scholar
• Stepanova AA, De Hoog GS, Vasilyeva N. 2016. Intra- and interspecific diversity of ultrastructural markers in Scedosporium. Fungal Biol. 120:147–154. doi:10.1016/j.funbio.2015.08.004.
   PubMed Web of Science ®Google Scholar
• Vila TV, Rozental S, de Sá Guimarães CM. 2015. A new model of in vitro fungal biofilms formed on human nail fragments allows reliable testing of laser and light therapies against onychomycosis. Lasers Med Sci. 30:1031–1039. doi:10.1007/s10103-014-1689-y.
   PubMed Web of Science ®Google Scholar
• Villena GK, Fujikawa T, Tsuyumu S, Gutiérrez-Correa M. 2010. Structural analysis of biofilms and pellets of Aspergillus niger by confocal laser scanning microscopy and cryo scanning electron microscopy. Bioresour Technol. 101:1920–1926. doi:10.1016/j.biortech.2009.10.036.
   PubMed Web of Science ®Google Scholar
• Walraven CJ, Lee SA. 2013. Antifungal lock therapy. Antimicrob Agents Chemother. 57:1–8. doi:10.1128/AAC.01351-12.
   PubMed Web of Science ®Google Scholar
• Zhang X, Sun X, Wang Z, Zhang Y, Hou W. 2012. Keratitis-associated fungi form biofilms with reduced antifungal drug susceptibility. Invest Ophthalmol Vis Sci. 53:7774–7778. doi:10.1167/iovs.12-10810.
   PubMed Web of Science ®Google Scholar